1 study found for:    brim-3
Show Display Options
Rank Status Study
1 Active, not recruiting
Has Results
A Study of RO5185426 in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)
Condition: Malignant Melanoma
Interventions: Drug: RO5185426;   Drug: dacarbazine

Indicates status has not been verified in more than two years